litlas
ログインアカウント作成

Lothar Kanz

1987–2022 年に発表

149
論文数
28,116
被引用数
107
h 指数
149
i10 指数

被引用数

Lothar Kanz の年別被引用数1979 年: 被引用 4 件1987 年: 被引用 1 件1988 年: 被引用 5 件1989 年: 被引用 6 件1990 年: 被引用 4 件1991 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 7 件1994 年: 被引用 23 件1995 年: 被引用 31 件1996 年: 被引用 35 件1997 年: 被引用 44 件1998 年: 被引用 36 件1999 年: 被引用 61 件2000 年: 被引用 129 件2001 年: 被引用 194 件2002 年: 被引用 223 件2003 年: 被引用 242 件2004 年: 被引用 270 件2005 年: 被引用 256 件2006 年: 被引用 216 件2007 年: 被引用 179 件2008 年: 被引用 205 件2009 年: 被引用 165 件2010 年: 被引用 206 件2011 年: 被引用 205 件2012 年: 被引用 222 件2013 年: 被引用 214 件2014 年: 被引用 187 件2015 年: 被引用 202 件2016 年: 被引用 165 件2017 年: 被引用 185 件2018 年: 被引用 149 件2019 年: 被引用 514 件2020 年: 被引用 614 件2021 年: 被引用 602 件2022 年: 被引用 408 件2023 年: 被引用 299 件2024 年: 被引用 370 件2025 年: 被引用 150 件2026 年: 被引用 2 件1980〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,437 件、この内訳の 24.6%ドイツ: 引用元論文 1,305 件、この内訳の 13.2%イギリス: 引用元論文 602 件、この内訳の 6.1%イタリア: 引用元論文 561 件、この内訳の 5.7%フランス: 引用元論文 488 件、この内訳の 4.9%中国: 引用元論文 480 件、この内訳の 4.9%オランダ: 引用元論文 342 件、この内訳の 3.5%カナダ: 引用元論文 315 件、この内訳の 3.2%スイス: 引用元論文 291 件、この内訳の 2.9%スペイン: 引用元論文 282 件、この内訳の 2.9%日本: 引用元論文 270 件、この内訳の 2.7%オーストラリア: 引用元論文 251 件、この内訳の 2.5%
0%24.6%その他 22.9%

機関

分野

  • Medicine67.5%
  • Immunology and Microbiology17.7%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Neuroscience1%
  • Engineering0.4%
  • Materials Science0.3%
  • その他0.8%

トピック

  • Immunotherapy and Immune Responses4.6%
  • Immune Cell Function and Interaction4.6%
  • CAR-T cell therapy research3.9%
  • Lymphoma Diagnosis and Treatment3.8%
  • Acute Myeloid Leukemia Research3.7%
  • Hematopoietic Stem Cell Transplantation3.3%
  • その他76.1%

共著者

全論文

検索で開く
  1. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

    著者: Anna Paczulla, Kathrin Rothfelder, Simon Raffel, Martina Konantz, Julia Steinbacher, Hui Wang, Claudia Tandler, Marcelle Ndoh Mbarga, Thorsten Schaefer, Mattia Falcone, Eva Nievergall, Daniela Dörfel, Pauline Hanns, Jakob Passweg, Christoph Lutz, Juerg Schwaller, Robert Zeiser, Bruce R. Blazar, Michael A. Caligiuri, Stephan Dirnhofer, Pontus Lundberg, Lothar Kanz, Leticia Quintanilla‐Martínez, Alexander Steinle, Andreas Trumpp, Helmut R. Salih, Claudia Lengerke - Nature 2019 被引用: 393

  2. Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

    著者: Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot, Peter Kufer, Max S. Topp, Hermann Einsele, Richard Noppeney, Georg Heß, С. Каллерт, Andréas Mackensen, Kathrin Rupertus, Lothar Kanz, M. Libicher, Dirk Nagorsen, Gerhard Zugmaier, Matthias Klinger, Andreas Wolf, B Dorsch, Beate D. Quednau, Margit Schmidt, J. Scheele, Patrick A. Baeuerle, Eugen Leo, Ralf C. Bargou - Journal of Clinical Oncology 2016 被引用: 421

  3. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    著者: for the SAKK and the German CML Study Group, Rüdiger Hehlmann, Michael Lauseker, Susanne Saußele, Markus Pfirrmann, Stefan W. Krause, Hans‐Jochem Kolb, Andreas Neubauer, Dieter K. Hossfeld, C. Nerl, Aloïs Gratwohl, Gabriela M. Baerlocher, Dominik Heim, Tim H. Brümmendorf, Alice Fabarius, Claudia Haferlach, Brigitte Schlegelberger, Marcus Müller, Sabine Jeromin, Ulrike Proetel, Katharina Kohlbrenner, Astghik Voskanyan, Sébastien Rinaldetti, Wolfgang Seifarth, Birgit Spieß, Leopold Balleisen, M-E Goebeler, Mathias Hänel, Anthony D. Ho, Jolanta Dengler, Christiane Falge, Lothar Kanz, Stephan Kremers, Andreas Burchert, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, H. W. Lindemann, Cornelius F. Waller, M. Pfreundschuh, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiřı́ Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland J. Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, W. Gaßmann, Antonio Pezzutto, Michael Schenk, Peter Brossart, Thomas Geer, Stephan Bildat, E. Schäfer, Andreas Hochhaus, Joerg Hasford - Leukemia 2017 被引用: 339

  4. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

    著者: Eckhard Thiel, Agnieszka Korfel, Peter Martus, Lothar Kanz, Frank Griesinger, Michael Rauch, Alexander Röth, Bernd Hertenstein, Theda von Toll, Thomas Hundsberger, H.‐G. Mergenthaler, Malte Leithäuser, Tobias Birnbaum, Lars Fischer, Kristoph Jahnke, Ulrich Herrlinger, Ludwig Plaßwilm, Thomas Nägele, Torsten Pietsch, Michael Bamberg, Michael Weller - The Lancet Oncology 2010 被引用: 622

  5. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party

    著者: Jörg Henes, Maria Carolina Oliveira, Myriam Labopin, Manuela Badoglio, Hans Ulrich Scherer, Nicoletta Del Papa, Thomas Daikeler, Marc Schmalzing, Roland Schroers, Thierry Martin, G. Pugnet, Belinda Pinto Simões, David Michonneau, Erik W.A. Marijt, Bruno Lioure, Jacques Olivier Bay, John A. Snowden, Montserrat Rovira, Anne Huynh, Francesco Onida, Lothar Kanz, Zora Marjanovic, Dominique Farge - Haematologica 2020 被引用: 121

  6. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

    著者: Helmut R. Salih, Holger Antropius, Friederike Gieseke, Stefan Lutz, Lothar Kanz, Hans‐Georg Rammensee, Alexander Steinle - Blood 2003 被引用: 532

  7. Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

    著者: Susanne M. Rittig, Maik Haentschel, Katrin J Weimer, Annkristin Heine, Martin Müller, Wolfram Brugger, Marius Horger, Olga Maksimovic, Arnulf Stenzl, Ingmar Hoerr, Hans‐Georg Rammensee, Tobias A.W. Holderried, Lothar Kanz, Steve Pascolo, Peter Brossart - Molecular Therapy 2010 被引用: 219

  8. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

    著者: Eva Hoster, Andreas Rosenwald, Françoise Berger, Heinz‐Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas F.E. Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Stephan Stilgenbauer, Roswitha Forstpointner, Catherine Thiéblemont, Michael Hallek, Bertrand Coiffier, Ursula Vehling‐Kaiser, Réda Bouabdallah, Lothar Kanz, Michael Pfreundschuh, Christian Schmidt, Vincent Ribrag, Wolfgang Hiddemann, Michael Unterhalt, Johanna C. Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfgang Hiddemann - Journal of Clinical Oncology 2016 被引用: 362

  9. Human Signal-Regulatory Protein Is Expressed on Normal, But Not on Subsets of Leukemic Myeloid Cells and Mediates Cellular Adhesion Involving Its Counterreceptor CD47

    著者: Martina Seiffert, Charles Cant, Zhengjun Chen, Irène Rappold, Wolfram Brugger, Lothar Kanz, Eric J. Brown, Axel Ullrich, Hans‐Jörg Bühring - Blood 1999 被引用: 294

  10. Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial

    著者: Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Christian H. Geisler, Marek Trněný, Stephan Stilgenbauer, Florian Kaiser, Jeanette K. Doorduijn, Gilles Salles, Michał Szymczyk, Hervé Tilly, Lothar Kanz, Christian Schmidt, Pierre Feugier, Catherine Thiéblemont, Josée M. Zijlstra, Vincent Ribrag, Wolfgang Hiddemann, Christiane Pott, Michael Unterhalt, Martin Dreyling - Journal of Clinical Oncology 2019 被引用: 143

  11. High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network

    著者: Olivier Hermine, Linmiao Jiang, Jan Walewski, André Bosly, Catherine Thiéblemont, Michał Szymczyk, Christiane Pott, Gilles Salles, Pierre Feugier, Kai Hübel, Corinne Haïoun, Olivier Casasnovas, Christian Schmidt, Kamal Bouabdallah, Vincent Ribrag, Lothar Kanz, Jan Dürig, Bernd Metzner, David Sibon, Morgane Cheminant, Barbara Burroni, Wolfgang Hiddemann, Wolfgang Hiddemann, Michael Unterhalt, Eva Hoster, Martin Dreyling, on behalf of the European Mantle Cell Lymphoma Network - Journal of Clinical Oncology 2022 被引用: 56

  12. Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience

    著者: Christian Kollmannsberger, K. Mross, A. Jakob, Lothar Kanz, Carsten Bokemeyer - Oncology 1999 被引用: 215

  13. The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1

    著者: Robert Möhle, Frank Bautz, Shahin Rafii, Malcolm A.S. Moore, Wolfram Brugger, Lothar Kanz - Blood 1998 被引用: 635

  14. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

    著者: Andreas Engert, Heinz Haverkamp, Carsten Kobe, Jana Marková, Christoph Renner, Antony D. Ho, Josée M. Zijlstra, Zdeněk Král, Michael Fuchs, Michael Hallek, Lothar Kanz, Hartmut Döhner, Bernd Dörken, Nicole Engel, Max S. Topp, Susanne Klutmann, Holger Amthauer, Andreas Bockisch, Regine Kluge, Clemens Kratochwil, Otmar Schober, Richard Greil, Reinhard Andreesen, Michael Kneba, Michael Pfreundschuh, Harald Stein, Hans Theodor Eich, Rolf‐Peter Müller, Markus Dietlein, Peter Borchmann, Volker Diehl - The Lancet 2012 被引用: 632

  15. Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation

    著者: Christoph Schmid, Liesbeth C. de Wreede, Anja van Biezen, Jürgen Finke, Gerhard Ehninger, Arnold Ganser, Liisa Volin, Dietger Niederwieser, Dietrich W. Beelen, P Alessandrino, Lothar Kanz, Michael Schleuning, Jakob Passweg, Hendrik Veelken, Johan Maertens, Jan J. Cornelissen, Didier Blaise, Martin Gramatzki, Nöel Milpied, Ibrahim Yakoub‐Agha, Ghulam Mufti, Montserrat Rovira, Renate Arnold, Théo de Witte, Marie Robin, Nicolaus Kröger - Haematologica 2017 被引用: 128

  16. Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

    著者: Donal P. McLornan, Richard Szydlo, Linda Köster, Yves Chalandon, Marie Robin, Christine Wolschke, Dietrich W. Beelen, Gerard Socié, Martin Bornhäuser, Emanuele Angelucci, Dietger Niederwieser, Arnim Gerbitz, Jürgen Finke, Antonı́n Vı́tek, Maija Itälä‐Remes, Aleksandar Radujkovic, Lothar Kanz, Victoria Potter, Patrice Chevallier, Matthias Stelljes, Eefke Petersen, Stephen Robinson, Xavier Poiré, Evgeny Klyuchnikov, Juan Carlos Hernández‐Boluda, Tomasz Czerw, Patrick Hayden, Nicolaus Kröger, Ibrahim Yakoub‐Agha - Biology of Blood and Marrow Transplantation 2019 被引用: 98

  17. Novel Markers for the Prospective Isolation of Human MSC

    著者: Hans‐Jörg Bühring, Venkata Lokesh Battula, Sabrina Treml, B. Schewe, Lothar Kanz, Wichard Vogel - Annals of the New York Academy of Sciences 2007 被引用: 453

  18. Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

    著者: Lida Kalmanti, Susanne Saußele, Michael Lauseker, M. C. Muller, Christian Dietz, Linda Heinrich, Benjamin Hanfstein, Ulrike Proetel, Alice Fabarius, Stefan W. Krause, Sébastien Rinaldetti, Jolanta Dengler, Christiane Falge, Elisabeth Oppliger Leibundgut, Andreas Burchert, Andreas Neubauer, Lothar Kanz, Frank Stegelmann, Michael Pfreundschuh, Karsten Spiekermann, Christof Scheid, Markus Pfirrmann, Andreas Hochhaus, Joerg Hasford, R. Hehlmann, for the SAKK and the German CML Study-Group - Leukemia 2015 被引用: 274

  19. Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation

    著者: Lena Axt, Aline Naumann, J. Toennies, Sebastian P. Haen, Wichard Vogel, Dominik Schneidawind, Stefan Wirths, R. Moehle, C. Faul, Lothar Kanz, Steffen Axt, Wolfgang Bethge - Bone Marrow Transplantation 2019 被引用: 109

  20. Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

    著者: Hermann Einsele, Eddy Roosnek, Nathalie Rufer, Christian Sinzger, Susanne Riegler, Jürgen Löffler, Ulrich Grigoleit, Arnaud Moris, Hans‐Georg Rammensee, Lothar Kanz, Annette Kleihauer, Friederike Frank, Gerhard Jahn, Holger Hebart - Blood 2002 被引用: 701

  21. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

    著者: Olivier Hermine, Eva Hoster, Jan Walewski, André Bosly, Stephan Stilgenbauer, Catherine Thiéblemont, Michał Szymczyk, Réda Bouabdallah, Michael Kneba, Michael Hallek, Gilles Salles, Pierre Feugier, Vincent Ribrag, Josef Birkmann, Roswitha Forstpointner, Corinne Haïoun, Mathias Hänel, Olivier Casasnovas, Jürgen Finke, Norma Peter, Kamal Bouabdallah, Catherine Sebban, Thomas Fischer, Ulrich Dührsen, Bernd Metzner, Georg Maschmeyer, Lothar Kanz, Christian Schmidt, Richard Delarue, Nicole Brousse, Wolfgang Hiddemann, Elizabeth Macintyre, Marie‐Hélène Delfau‐Larue, Christiane Pott, Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling - The Lancet 2016 被引用: 401

  22. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    著者: Alice Fabarius, Armin Leitner, Andreas Hochhaus, Martin C. Müller, Benjamin Hanfstein, Claudia Haferlach, Gudrun Göhring, Brigitte Schlegelberger, Martine Jotterand, Andreas Reiter, Susanne Jung-Munkwitz, Ulrike Proetel, Juliana Schwaab, Wolf‐Karsten Hofmann, Jörg Schubert, Hermann Einsele, Anthony D. Ho, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, Michael Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M. Baerlocher, Michael Lauseker, Markus Pfirrmann, Joerg Hasford, Susanne Saußele, Rüdiger Hehlmann, for the Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group - Blood 2011 被引用: 290

  23. SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma

    著者: Petra M. Bareiss, Anna Paczulla, Hui Wang, Rebekka Schairer, Stefan Wiehr, Ursula Kohlhofer, Oliver C. Rothfuss, Anna Fischer, Sven Perner, Annette Staebler, D. Wallwiener, Falko Fend, Tanja Fehm, Bernd J. Pichler, Lothar Kanz, Leticia Quintanilla‐Martínez, Klaus Schulze‐Osthoff, Frank Eßmann, Claudia Lengerke - Cancer Research 2013 被引用: 152

  24. Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

    著者: B. Hanfstein, Michael Lauseker, R Hehlmann, Susanne Saußele, Philipp Erben, Christian Dietz, Alice Fabarius, Ulrike Proetel, Susanne Schnittger, Claudia Haferlach, Stefan W. Krause, Jörg Schubert, Hermann Einsele, Mathias Hänel, Jolanta Dengler, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, M Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M. Baerlocher, Markus Pfirrmann, Joerg Hasford, W.‐K. Hofmann, Andreas Hochhaus, Martin Müller, for the SAKK and the German CML Study Group - Haematologica 2014 被引用: 119